Survival and cArdiovascular eVents in Patients With Acute Myocardial Infarction
Recruiting
- Conditions
- Coronary Artery DiseaseAcute Myocardial Infarction
- First Posted Date
- 2024-07-05
- Last Posted Date
- 2024-07-05
- Lead Sponsor
- Peking University First Hospital
- Target Recruit Count
- 10000
- Registration Number
- NCT06489080
- Locations
- 🇨🇳
Division of Cardiology, Peking University First Hospital, Beijing, Beijing, China
Evaluation of Transrectal Perilesional Biopsy in Diagnosis of Prostate Cancer
Not Applicable
Completed
- Conditions
- Prostate Cancer
- Interventions
- Procedure: Transrectal perilesional/regional systematic biopsy (PB/RSB)Procedure: Combination of transrectal systematic biopsy and targeted biopsy
- First Posted Date
- 2024-07-01
- Last Posted Date
- 2025-04-08
- Lead Sponsor
- Peking University First Hospital
- Target Recruit Count
- 380
- Registration Number
- NCT06482658
- Locations
- 🇨🇳
Peking University First Hospital, Beijing, Beijing, China
Evaluation of Perilesional Biopsy in Diagnosis of Prostate Cancer
Not Applicable
Recruiting
- Conditions
- Prostate Cancer
- Interventions
- Procedure: Perilesional/regional systematic biopsyProcedure: Combination of systematic biopsy and targeted biopsy
- First Posted Date
- 2024-07-01
- Last Posted Date
- 2024-07-23
- Lead Sponsor
- Peking University First Hospital
- Target Recruit Count
- 300
- Registration Number
- NCT06482645
- Locations
- 🇨🇳
Peking University First Hospital, Beijing, Beijing, China
Repetitive Transcranial Magnetic Stimulation and Postoperative Neurocognitive Recovery
Not Applicable
Not yet recruiting
- Conditions
- Repetitive Transcranial Magnetic StimulationCognitive ImpairmentPostoperative Neurocognitive DisorderOlder PatientsDelayed Neurocognitive Recovery
- Interventions
- Device: Repetitive transcranial magnetic stimulationDevice: Sham stimulation
- First Posted Date
- 2024-07-01
- Last Posted Date
- 2025-05-08
- Lead Sponsor
- Peking University First Hospital
- Target Recruit Count
- 568
- Registration Number
- NCT06482749
- Locations
- 🇨🇳
Peking University Shenzhen Hospital, Shenzhen, Guangzhou, China
🇨🇳Xijing Hospital, Air Force Medical University, Xi'an, Shannxi, China
🇨🇳Peking University First Hospital, Beijing, Beijing, China
Blood Biomarkers for Screening of Alzheimer's Disease
Recruiting
- Conditions
- Alzheimer's DiseaseBlood Biomarkers
- Interventions
- Diagnostic Test: Blood biomarker
- First Posted Date
- 2024-06-27
- Last Posted Date
- 2024-06-27
- Lead Sponsor
- Peking University First Hospital
- Target Recruit Count
- 180
- Registration Number
- NCT06477484
- Locations
- 🇨🇳
Peking University First Hospital, Beijing, Beijing, China
Neoadjuvant Radiotherapy for High-risk UTUC
Not yet recruiting
- Conditions
- Urothelial Carcinoma of the Renal Pelvis and Ureter
- Interventions
- Radiation: Neoadjuvant radiotherapyCombination Product: Neoadjuvant drug therapy
- First Posted Date
- 2024-06-25
- Last Posted Date
- 2024-06-25
- Lead Sponsor
- Peking University First Hospital
- Target Recruit Count
- 40
- Registration Number
- NCT06472752
- Locations
- 🇨🇳
Departmeng of Urology, Peking University First Hospital, Beijing, China
Dexmedetomidine-Esketamine Combination for Sedation and Analgesia in ICU Patients
Not Applicable
Not yet recruiting
- Conditions
- Intensive Care UnitsEsketamineAgedVentilators, MechanicalDexmedetomidineDelirium
- Interventions
- Drug: Dexmedetomidine-Esketamine Combination
- First Posted Date
- 2024-06-21
- Last Posted Date
- 2024-10-08
- Lead Sponsor
- Peking University First Hospital
- Target Recruit Count
- 1508
- Registration Number
- NCT06468436
- Locations
- 🇨🇳
Tianjin Medical University General Hospital, Tianjin, Tianjin, China
🇨🇳Peking University International Hospital, Beijing, Beijing, China
🇨🇳Peking University First Hospital, Beijing, Beijing, China
Fractional Flow Reserve-guided Stenting Versus Medical Therapy in Atherosclerosis Renal Artery Stenosis
Not Applicable
Recruiting
- Conditions
- Secondary Hypertension Renal ArterialRenal Artery Stenosis Atherosclerotic
- Interventions
- First Posted Date
- 2024-06-07
- Last Posted Date
- 2024-08-16
- Lead Sponsor
- Peking University First Hospital
- Target Recruit Count
- 200
- Registration Number
- NCT06447740
- Locations
- 🇨🇳
Peking University First Hospital, Beijing, Beijing, China
A Study of Molecular Subtyping-based Therapeutic Strategies for Cutaneous T-cell Lymphoma
Recruiting
- Conditions
- Cutaneous T-Cell Lymphoma/Mycosis FungoidesCutaneous T Cell Lymphoma
- Interventions
- Other: molecular subtype based treatment
- First Posted Date
- 2024-05-31
- Last Posted Date
- 2024-05-31
- Lead Sponsor
- Peking University First Hospital
- Target Recruit Count
- 100
- Registration Number
- NCT06436677
- Locations
- 🇨🇳
Peking University First Hospital, Beijing, Beijing, China
🇨🇳Peking University Third Hospital, Beijing, Beijing, China
🇨🇳Beijing Cancer Hospital, Beijing, Beijing, China
Evaluation of Efficacy and Safety of Combination Therapy of Henagliflozin Proline, Retagliptin and Metformin in New Diagnosed Type 2 Diabetes Patients
Phase 4
Not yet recruiting
- Conditions
- Type 2 Diabetes
- Interventions
- Drug: Combination therapyDrug: Sequential treatment group
- First Posted Date
- 2024-05-16
- Last Posted Date
- 2024-05-16
- Lead Sponsor
- Peking University First Hospital
- Target Recruit Count
- 160
- Registration Number
- NCT06417489
© Copyright 2025. All Rights Reserved by MedPath